Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081

Coutinho, Conrado Milani; Warshaw, Meredith G.; Duarte, Geraldo; Stek, Alice; FCPaed(SA), Avy Violari; Hofer, Cristina B.; Deville, Jaime G.; Ngocho, James Samwel; Pilotto, José Henrique; Correa Jr., Mario Dias; Shapiro, David E.; Fuller, Trevon L.; Chakhtoura, Nahida; Mirochnick, Mark; João, Esaú C..
Artículo en Inglés | ARCA | ID: arc-57286

Documentos relacionados

  1. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081.
  2. Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens.
  3. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term.
  4. The impact of primary care physician density on perinatal health: Evidence from a natural experiment.
  5. Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil.
  6. Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.
  7. Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro.
  8. Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.
  9. A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy.
  10. Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight.